PTPN2 Deficiency Enhances Programmed T Cell Expansion and Survival Capacity of Activated T Cells

Manipulating molecules that impact T cell receptor (TCR) or cytokine signaling, such as the protein tyrosine phosphatase non-receptor type 2 (PTPN2), has significant potential for advancing T cell-based immunotherapies. Nonetheless, it remains unclear how PTPN2 impacts the activation, survival, and...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cell Rep
Egile Nagusiak: Flosbach, Markus, Oberle, Susanne G., Scherer, Stefanie, Zecha, Jana, von Hoesslin, Madlaina, Wiede, Florian, Chennupati, Vijaykumar, Cullen, Jolie G., List, Markus, Pauling, Josch K., Baumbach, Jan, Kuster, Bernhard, Tiganis, Tony, Zehn, Dietmar
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Cell Press 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7408006/
https://ncbi.nlm.nih.gov/pubmed/32726622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2020.107957
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak